Comparison of Azacitidine and Decitabine for the Treatment of Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis

被引：0
|
作者：
Saiz-Rodriguez, Miriam
Cuevas, Beatriz
Martinez-Cuadron, David
Campuzano, Veronica
Cuevas, Maria Victoria
Hermida, Gerardo
Alvarez, Rodolfo
Gonzalez-Lopez, Tomas Jose
Diaz-Galvez, Francisco Javier
Alcaraz, Raquel
de Vicente, Pilar
Sanz, Miguel A.
Montesinos, Pau
Labrador, Jorge
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-141539
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] A systematic review and meta-analysis on the risk factors of acute myeloid leukemia
    Guo, Yanrong
    Wang, Wenwen
    Sun, Huali
    TRANSLATIONAL CANCER RESEARCH, 2022, 11 (04) : 796 - 804
  • [22] Venetoclax with decitabine or azacitidine in the first-line treatment of acute myeloid leukemia
    Bouligny, Ian M.
    Murray, Graeme
    Doyel, Michael
    Patel, Tilak
    Boron, Josh
    Tran, Valerie
    Gor, Juhi
    Hang, Yiwei
    Alnimer, Yanal
    Zacholski, Kyle
    Venn, Chad
    Wages, Nolan A.
    Grant, Steven
    Maher, Keri R.
    EJHAEM, 2023, 4 (02): : 381 - 392
  • [23] High-Dose Cytarabine in Acute Myeloid Leukemia Treatment: A Systematic Review and Meta-Analysis
    Li, Wei
    Gong, Xiaoyuan
    Sun, Mingyuan
    Zhao, Xingli
    Gong, Benfa
    Wei, Hui
    Mi, Yingchang
    Wang, Jianxiang
    PLOS ONE, 2014, 9 (10):
  • [24] Venetoclax with decitabine or azacitidine in relapsed or refractory acute myeloid leukemia
    Bouligny I.M.
    Murray G.
    Doyel M.
    Patel T.
    Boron J.
    Tran V.
    Gor J.
    Hang Y.
    Alnimer Y.
    Ho T.
    Zacholski K.
    Venn C.
    Wages N.A.
    Grant S.
    Maher K.R.
    Medical Oncology, 41 (3)
  • [25] Efficacy of decitabine combined with allogeneic hematopoietic stem cell transplantation in the treatment of recurrent and refractory acute myeloid leukemia (AML): A systematic review and meta-analysis
    Zhang, Donghui
    Chen, Jiahui
    MEDICINE, 2022, 101 (37) : E30644
  • [26] Comparison Between Decitabine and Azacitidine for the Treatment of Myelodysplastic Syndrome: A Meta-Analysis With 1392 Participants
    Xie, Mixue
    Jiang, Qi
    Xie, Yanhui
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (01): : 22 - 28
  • [27] A systematic review and meta-analysis of the efficacy and adverse events of azacitidine-plus-lenalidomide treatment for patients with acute myeloid leukemia, myelodysplastic syndromes and chronic myelomonocytic leukemia
    Kunacheewa, Chutima
    Thongthang, Pakaporn
    Ungprasert, Patompong
    Utchariyaprasit, Eakkapol
    Owattanapanich, Weerapat
    HEMATOLOGY, 2019, 24 (01) : 498 - 506
  • [28] Elderly patient with acute myeloid leukemia refractory to decitabine who responded to treatment with azacitidine
    Galvez, K.
    Combariza, J.
    Gomez, M.
    LEUKEMIA RESEARCH, 2013, 37 : S102 - S102
  • [29] Meta-analysis of the efficacy of venetoclax and azacitidine combination therapy and azacitidine monotherapy for treating acute myeloid leukemia
    Xie, Yuqin
    Wei, Xueqin
    Wang, Weiwei
    Liao, Changsheng
    Han, Pengfei
    Yu, Yanhui
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2024, 27 (04)
  • [30] The Role of Anti-CD33 for the Treatment of Acute Myeloid Leukemia - Systematic Review and Meta-Analysis
    Gurion, Ronit
    Gafter-Gvili, Anat
    Ram, Ron
    Vidal, Liat
    Raanani, Pia
    Shpilberg, Ofer
    BLOOD, 2012, 120 (21)
12345